Forecast: Pharmaceutical Industry Exports in Italy

The pharmaceutical industry exports in Italy have demonstrated fluctuating growth over the past decade. Starting at $24.85 billion in 2013, exports saw varying year-on-year changes with some notable declines, such as in 2015 (-20.98%) and subsequent recoveries in other years, e.g., 2017 (18.66%). By 2023, the value stood at $41.21 billion, with year-on-year growth relatively stable in the recent years, specifically 3.96% in 2022 and 3.76% in 2023. Observing a 5-year CAGR from 2019 to 2023, the average annual growth rate was approximately 7.07%. Looking forward, forecasts from 2024 to 2028 suggest a more moderate growth trend with a 5-year CAGR of 2.57% and an overall growth rate of 13.51% by 2028.

Future trends to watch for:

  • Regulatory changes: Any modifications to pharmaceutical regulations in main markets could impact export volumes and values.
  • Technological advancements: Innovation in drug development and manufacturing processes might drive growth.
  • Global health trends: Shifts in global health demands or responses to pandemics can influence export dynamics.